BNT162b2 COVID-19疫苗诱导的免疫性血小板减少性紫癜

IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL

Case Reports in Medicine Pub Date : 2022-04-12 DOI:10.1155/2022/5603919

A. Ghosh, S. Bhushan, L. D. López, D. Sampat, Z. Salah, C. Hatoum

{"title":"BNT162b2 COVID-19疫苗诱导的免疫性血小板减少性紫癜","authors":"A. Ghosh, S. Bhushan, L. D. López, D. Sampat, Z. Salah, C. Hatoum","doi":"10.1155/2022/5603919","DOIUrl":null,"url":null,"abstract":"Immune thrombocytopenic purpura (ITP) has been reported following vaccinations such as MMR as well as after viral infections such as hepatitis C and HIV. Few case reports have been reported of ITP after COVID-19 infections and COVID-19 vaccines. Herein, we present a patient who presented with severe ITP with a platelet count of 0 after receiving the second dose of the BNT162b2 mRNA COVID-19 vaccine (also known as the Pfizer BioNTech). She subsequently recovered with a prolonged treatment course.","PeriodicalId":9627,"journal":{"name":"Case Reports in Medicine","volume":"14 1","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2022-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura\",\"authors\":\"A. Ghosh, S. Bhushan, L. D. López, D. Sampat, Z. Salah, C. Hatoum\",\"doi\":\"10.1155/2022/5603919\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Immune thrombocytopenic purpura (ITP) has been reported following vaccinations such as MMR as well as after viral infections such as hepatitis C and HIV. Few case reports have been reported of ITP after COVID-19 infections and COVID-19 vaccines. Herein, we present a patient who presented with severe ITP with a platelet count of 0 after receiving the second dose of the BNT162b2 mRNA COVID-19 vaccine (also known as the Pfizer BioNTech). She subsequently recovered with a prolonged treatment course.\",\"PeriodicalId\":9627,\"journal\":{\"name\":\"Case Reports in Medicine\",\"volume\":\"14 1\",\"pages\":\"\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2022-04-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports in Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2022/5603919\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/5603919","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 3

摘要

免疫性血小板减少性紫癜(ITP)已报道接种疫苗后，如MMR以及病毒感染后，如丙型肝炎和艾滋病毒。COVID-19感染和COVID-19疫苗后ITP病例报告较少。在此，我们报告了一位在接受第二剂BNT162b2 mRNA COVID-19疫苗(也称为辉瑞BioNTech)后出现血小板计数为0的严重ITP患者。经过长时间的治疗，她后来康复了。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura

Immune thrombocytopenic purpura (ITP) has been reported following vaccinations such as MMR as well as after viral infections such as hepatitis C and HIV. Few case reports have been reported of ITP after COVID-19 infections and COVID-19 vaccines. Herein, we present a patient who presented with severe ITP with a platelet count of 0 after receiving the second dose of the BNT162b2 mRNA COVID-19 vaccine (also known as the Pfizer BioNTech). She subsequently recovered with a prolonged treatment course.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Case Reports in Medicine MEDICINE, GENERAL & INTERNAL-

CiteScore

1.70

自引率

0.00%

发文量

审稿时长

13 weeks